CHE Chemed Corporation
Health Care, filed as CHEMED CORP NEW (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab
No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.
Insider trades
Open-market buys and sales by CHE's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $8.8M sold by 5 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Kevin J McNamara CEOSale$1M 2,000 shares at $513.45 2.9% of stakeTraded Sep 28 Filed Sep 30
-
Kevin J McNamara CEOSale$1M 2,000 shares at $501.40 2.8% of stakeTraded Sep 18 Filed Sep 21
-
Spencer S Lee executive vice presidentSale$541K 1,000 shares at $541.04 6.7% of stakeTraded Aug 21 Filed Aug 24
-
Kevin J McNamara CEOSale$1.1M 2,000 shares at $541.16 2.8% of stakeTraded Aug 21 Filed Aug 24
-
Kevin J McNamara CEOSale$1.1M 2,000 shares at $539.51 2.8% of stakeTraded Aug 3 Filed Aug 4
-
Patrick P Grace DirectorSale$101K 190 shares at $532.00 5.1% of stakeTraded Jul 31 Filed Aug 3
-
Andrea R Lindell DirectorSale$603K 1,347 shares at $447.33 23% of stakeTraded Jun 9 Filed Jun 10
-
George J Walsh III DirectorSale$219K 500 shares at $437.83 14% of stakeTraded May 29 Filed May 29
-
Patrick P Grace DirectorSale$26K 60 shares at $425.78 1.8% of stakeTraded May 8 Filed May 8
-
Kevin J McNamara CEOSale$842K 2,000 shares at $421.13 2.2% of stakeTraded May 1 Filed May 4
-
Kevin J McNamara CEOSale$554K 1,500 shares at $369.37 1.6% of stakeTraded Mar 27 Filed Mar 30
-
Kevin J McNamara CEOSale$806K 2,000 shares at $403.18 2.1% of stakeTraded Mar 12 Filed Mar 13
-
Kevin J McNamara CEOSale$875K 2,000 shares at $437.55 2.1% of stakeTraded Nov 24, 2025 Filed Nov 25, 2025
Also filed in the last 12 months, not counted as buying or selling: 17 option exercises, 11 share withholdings for taxes, 7 stock grants, and 2 gifts.
Congress
2 members of Congress traded CHE in the last three years: 1 buy and 2 sales. 1 member listed it in 2025 annual reports.
-
Lisa C. McClain
Buy
$1K–$15K
Jun 24, 2025
filed Aug 13, 2025
-
Byron Donalds
Sell
$1K–$15K
Mar 6, 2025
filed Apr 14, 2025
-
Byron Donalds
Sell
$1K–$15K
Mar 6, 2025
filed Apr 14, 2025
SEC filings
Recent issuer filings from EDGAR, 12 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.01,2.03,9.01 | Filing Doc | |
| DEF 14A | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $500.84M | $394.75M | $302.62M |
| Total non-current assets * | $1.17B | $1.27B | $1.24B |
| Total assets | $1.67B | $1.67B | $1.54B |
| Total current liabilities | $312.05M | $285.7M | $287.13M |
| Total non-current liabilities * | $248.17M | $263.89M | $271.65M |
| Total equity | $1.11B | $1.12B | $0.979B |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.